CME Group Inc. (NASDAQ:CME) had its price target hoisted by equities researchers at Royal Bank Of Canada from $135.00 to $147.00 in a research note issued to investors on Monday. The firm presently has an “outperform” rating on the financial services provider’s stock. Royal Bank Of Canada’s target price suggests a potential upside of 7.94% from the company’s current price.

Other equities research analysts also recently issued research reports about the company. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Jefferies Group LLC reissued a “buy” rating and set a $134.00 price target (up previously from $128.00) on shares of CME Group in a research report on Monday, July 17th. Citigroup Inc. started coverage on CME Group in a research report on Wednesday, July 12th. They set a “buy” rating and a $140.00 price target for the company. Deutsche Bank AG lowered their price target on CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a research report on Tuesday, July 4th. Finally, UBS AG reissued a “buy” rating and set a $135.00 price target (up previously from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $137.22.

CME Group (CME) opened at 136.19 on Monday. The stock has a market capitalization of $46.29 billion, a PE ratio of 27.80 and a beta of 0.73. CME Group has a 12-month low of $98.95 and a 12-month high of $138.49. The stock’s 50 day moving average price is $132.46 and its 200-day moving average price is $123.94.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925.00 million during the quarter, compared to the consensus estimate of $931.05 million. During the same quarter in the previous year, the business earned $1.14 earnings per share. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. Analysts expect that CME Group will post $4.81 earnings per share for the current year.

WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/10/18/cme-group-inc-cme-pt-raised-to-147-00.html.

In other CME Group news, insider Hilda Harris Piell sold 1,350 shares of the business’s stock in a transaction dated Thursday, October 5th. The stock was sold at an average price of $138.00, for a total transaction of $186,300.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Wednesday, October 11th. The stock was sold at an average price of $136.83, for a total value of $342,075.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 49,594 shares of company stock worth $6,239,015. 0.57% of the stock is currently owned by insiders.

Large investors have recently added to or reduced their stakes in the stock. RMB Capital Management LLC lifted its stake in shares of CME Group by 3.1% in the first quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after acquiring an additional 3,501 shares in the last quarter. Capital Advisors Inc. OK lifted its stake in shares of CME Group by 10.7% in the second quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock worth $10,587,000 after acquiring an additional 8,198 shares in the last quarter. Marvin & Palmer Associates Inc. lifted its stake in shares of CME Group by 100.7% in the second quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock worth $7,173,000 after acquiring an additional 28,745 shares in the last quarter. Thrivent Financial For Lutherans lifted its stake in shares of CME Group by 5.6% in the first quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock worth $1,485,000 after acquiring an additional 660 shares in the last quarter. Finally, Captrust Financial Advisors acquired a new position in shares of CME Group in the second quarter worth about $693,000. Institutional investors and hedge funds own 82.62% of the company’s stock.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.